Commentary: Republican action threatens to raise health care premiums lowered by the Inflation Reduction Act
In a twist of fate, I was advocating for accessible health care when I first felt pain in my left breast. Like many women, ...
Ludlow Solar Project gets $2.3 million from Inflation Reduction Act
MMWEC said Monday it believes it is one of the first public power joint action agencies to benefit from this clean energy tax ...
IRS has improved taxpayer services but is slow to resolve ID theft, an independent watchdog says
An independent watchdog finds the IRS has improved its overall taxpayer service but is slow to resolve certain identity theft ...
Opinion: Biden left us with a ‘Prius economy.’ It’s time for something different.
The problem with the Inflation Reduction Act was that it was an awkward compromise between neoliberal, market-based policy ...
Hosted on MSN6d
How To Save on Green Improvements Under Inflation Reduction Act
Tax credits for energy-efficient home improvements are extended and expanded by the Inflation Reduction Act. Wayne Osmond, ...
IRS taxpayer services improve, but identity theft cases linger, watchdog says
The report, while highlighting positive strides made by the agency, also underscores areas that still require substantial ...
Biden administration achieves fourth record-breaking ACA enrollment ahead of exit
The Biden administration has achieved a fourth consecutive record year in HealthCare.gov Marketplace enrollment, one week ...
New AARP Report: Top Medicare Part D Drugs See Average Lifetime Price Hike of 98%
Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...
Taxpayer Advocate urges Congress to preserve IRS funding for service, technology
The National Taxpayer Advocate has urged Congress to preserve IRS funding for taxpayer service and technology amid Republican scrutiny.
Ozempic, Trulicity among Medicare's priciest drugs, report finds
Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...